# IsoPlexis Corporation (ISO)

Source: https://www.quantisnow.com/company/ISO
Generated: 2026-11-10T22:02:15.038Z

- Ticker: ISO
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IPO year: 2021
- Website: isoplexis.com

## About

IsoPlexis Corporation, a life sciences company, provides solutions for the development of curative medicines and personalized therapeutics in the United States and Europe. The company offers single cell proteomics platform, including instruments, chip consumables, and software that provides an end-to-end solution to view of protein function at an individual cellular level. It provides IsoLight and IsoSpark instruments; IsoCode chips that offer multiplexed chip solutions for single cell functional proteomics; CodePlex chips that provide multiplexed solutions for ultra-low volume bulk samples; and IsoSpeak software that offers dimensional data and automates analysis with an intuitive push button user interface to deliver same day single cell and bulk proteome visualizations without the need for highly specialized informatics professionals, as well as research support and services, and post-warranty services. The company was incorporated in 2013 and is based in Branford, Connecticut.

## Latest ISO news and filings

- 2023-06-15 20:15 UTC [SEC Schedule 13D] [SEC Form SC 13D/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13da-filed-by-isoplexis-corporation-amendment-4648316)
- 2023-03-31 12:32 UTC [SEC Form 15-12G filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-isoplexis-corporation-4277474)
- 2023-03-22 12:13 UTC [SEC Form 8-K] [IsoPlexis Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/isoplexis-corporation-filed-sec-form-8-k-entry-into-a-material-4233429)
- 2023-03-21 21:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-isoplexis-corporation-4231706)
- 2023-03-21 21:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-isoplexis-corporation-4231693)
- 2023-03-21 21:04 UTC [SEC Form 4] [SEC Form 4 filed by Khakhar Rajesh T.](https://www.quantisnow.com/insight/sec-form-4-filed-by-khakhar-rajesh-t-4231563)
- 2023-03-21 20:53 UTC [SEC Form 4] [SEC Form 4 filed by Myers Jason W.](https://www.quantisnow.com/insight/sec-form-4-filed-by-myers-jason-w-4231444)
- 2023-03-21 20:52 UTC [SEC Form 4] [SEC Form 4 filed by Ho Gregory P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-ho-gregory-p-4231425)
- 2023-03-21 20:50 UTC [SEC Form 4] [SEC Form 4 filed by Heath James R](https://www.quantisnow.com/insight/sec-form-4-filed-by-heath-james-r-4231422)
- 2023-03-21 20:48 UTC [SEC Form 4] [SEC Form 4 filed by Zhou Jing](https://www.quantisnow.com/insight/sec-form-4-filed-by-zhou-jing-4231404)
- 2023-03-21 20:47 UTC [SEC Form 4] [SEC Form 4 filed by Mackay Sean](https://www.quantisnow.com/insight/sec-form-4-filed-by-mackay-sean-4231395)
- 2023-03-21 20:46 UTC [SEC Form 4] [SEC Form 4 filed by Conley John G.](https://www.quantisnow.com/insight/sec-form-4-filed-by-conley-john-g-4231383)
- 2023-03-21 20:45 UTC [SEC Form 4] [SEC Form 4 filed by Rew Richard W. Ii](https://www.quantisnow.com/insight/sec-form-4-filed-by-rew-richard-w-ii-4231362)
- 2023-03-21 20:44 UTC [SEC Form 4] [SEC Form 4 filed by Strahley John](https://www.quantisnow.com/insight/sec-form-4-filed-by-strahley-john-4231349)
- 2023-03-21 20:41 UTC [SEC Form 4] [SEC Form 4 filed by Shamir Nachum](https://www.quantisnow.com/insight/sec-form-4-filed-by-shamir-nachum-4231333)
- 2023-03-21 13:10 UTC [SEC Form 25-NSE filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-isoplexis-corporation-4228412)
- 2023-03-21 12:02 UTC [Berkeley Lights Completes Acquisition of IsoPlexis Forming PhenomeX, the Functional Cell Biology Company](https://www.quantisnow.com/insight/berkeley-lights-completes-acquisition-of-isoplexis-forming-phenomex-the-functional-4227566)
- 2023-03-16 21:22 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-4214794)
- 2023-03-16 21:16 UTC [SEC Form 8-K] [IsoPlexis Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/isoplexis-corporation-filed-sec-form-8-k-submission-of-matters-to-4214755)
- 2023-03-14 20:24 UTC [SEC Form 4] [SEC Form 4: Heath James R exercised 201,888 shares at a strike of $0.36](https://www.quantisnow.com/insight/sec-form-4-heath-james-r-exercised-201888-shares-at-4200724)
- 2023-03-09 21:33 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-isoplexis-corporation-4182105)
- 2023-03-09 21:28 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-4181964)
- 2023-03-09 21:26 UTC [SEC Form 8-K] [IsoPlexis Corporation filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/isoplexis-corporation-filed-sec-form-8-k-other-events-4181937)
- 2023-03-02 21:53 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-isoplexis-corporation-4155628)
- 2023-03-02 13:09 UTC [SEC Form 10-K] [SEC Form 10-K filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-isoplexis-corporation-4150223)
- 2023-02-28 13:06 UTC [Market Insight] [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://www.quantisnow.com/insight/12-health-care-stocks-moving-in-tuesdays-pre-market-session-4129288)
- 2023-02-16 21:48 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-isoplexis-corporation-4079371)
- 2023-02-16 21:46 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-4079351)
- 2023-02-16 21:44 UTC [SEC Form 8-K] [IsoPlexis Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/isoplexis-corporation-filed-sec-form-8-k-entry-into-a-material-4079325)
- 2023-02-14 21:33 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-isoplexis-corporation-amendment-4064361)
- 2023-02-14 19:40 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-isoplexis-corporation-amendment-4061539)
- 2023-02-14 19:33 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-isoplexis-corporation-amendment-4061457)
- 2023-02-13 12:08 UTC [SEC Form DEFM14A] [SEC Form DEFM14A filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-defm14a-filed-by-isoplexis-corporation-4044871)
- 2023-02-07 22:16 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-4018567)
- 2023-02-02 18:40 UTC [SEC Form 4] [SEC Form 4: Conley John G. exercised 36,000 shares at a strike of $0.86, increasing direct ownership by 56% to 100,752 units](https://www.quantisnow.com/insight/sec-form-4-conley-john-g-exercised-36000-shares-at-3995360)
- 2023-02-01 14:26 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-isoplexis-corporation-amendment-3985839)
- 2023-01-27 22:11 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-3968190)
- 2023-01-27 21:16 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by IsoPlexis Corporation (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-isoplexis-corporation-amendment-3967400)
- 2023-01-12 21:07 UTC [SEC Form 425] [SEC Form 425 filed by IsoPlexis Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-isoplexis-corporation-3906931)
- 2023-01-12 21:07 UTC [Market Chatter] [IsoPlexis Announces Preliminary Unaudited Revenue For The Full Year Ended Dec 31, 2022 Total Revenue To Be In The Range Of $16.6M-$16.8M, Down 3%-4% YoY; Q4 Results Were Lower Than Expected Primarily Due To The Timing Of Customer Orders For Instruments](https://www.quantisnow.com/insight/isoplexis-announces-preliminary-unaudited-revenue-for-the-full-year-ended-3906921)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ISO
- Earnings history: https://www.quantisnow.com/earnings/ISO
- Dividend history: https://www.quantisnow.com/dividends/ISO
- Insider transactions: https://www.quantisnow.com/insiders/ISO
- Options chain: https://www.quantisnow.com/options/ISO
- SEC 8-K filings only: https://www.quantisnow.com/company/ISO/8-k
- RSS and alerts for ISO: https://www.quantisnow.com/docs/rss-feeds.md